Call for Abstracts

CDC, NIH, and NEHA are pleased to announce a Call for Abstracts for oral and poster presentations for the upcoming ICLB conference in Atlanta, Georgia.

Call for Abstracts Open: February 1, 2018
Deadline for Abstract Submission: March 5, 2018

Abstract submission has closed. Registration opens to the public on May 1.

Submission Criteria

The ICLB Program Committee will review all submissions for quality, relevance, potential impact, and originality. There is no limit on the number of abstracts submitted by an individual, but the submission of multiple, similar abstracts from the same investigator(s) or laboratory is discouraged.

  1. Quality: Abstracts should be well organized and easily understood. They are judged as indicators of what can be expected of the session.
  2. Relevance: Abstracts should be highly relevant to the fields of Lyme and other tickborne disease diagnostics, ecology, environmental health, epidemiology, medicine, microbiology, and pathogenesis.
  3. Impact: Abstracts should be timely, hypothesis-driven new work.  Abstracts including the following are discouraged: single case reports, open label drug trials, highly speculative accounts of clinical experience, and accounts of personal experience.   
  4. Originality: Abstracts regarding innovative techniques or ideas will be favorably considered. Research published in its entirety online in manuscript form prior to submission of the abstract should not be submitted. Abstracts submitted or presented at other meetings CAN be submitted for consideration at this ICLB meeting.
  5. Commercial content: Product promotion is not permitted. It is acceptable to use a product in a study or as a proof of concept.

Note: The ICLB Program Committee reserves the right to reject an abstract if it does not follow these submission guidelines. Proposals that are incomplete or late will not be considered.

ICLB Topic Areas

During submission, authors will be asked to select one of the following 5 topic areas for review and program planning of their abstract: 

Examples are listed below a topic to help guide decision-making.  

  • Clinical/Epidemiology
    • Clinical trials
    • Risk factor studies
    • Understanding surveillance numbers
    • Characterizing burden/patient population
    • Human vaccines/Antibody prophylaxis
    • Antibiotic prophylaxis
  • Laboratory Diagnostics
    • Diagnostic development/evaluation 
    • Diagnostic markers 
    • Molecular typing/genomes
  • Pathogenesis
    • Tick-host-pathogen interactions
    • Host immune defenses
    • Microbial physiology
    • Molecular genetics
  • Tick biology/Natural transmission cycles
    • Tick distribution and behavior
    • Tick physiology/Anti-tick vaccine targets
    • Natural infection in ticks and vertebrate reservoirs
  • Prevention
    • Environmental tick and pathogen control, including:
      • Suppression of host-seeking ticks
      • Host/reservoir-targeted control methods
      • Integrated tick/pathogen management
    • Behavioral risk factors for human-tick contact
    • Development/use of repellents and permethrin-treated clothing
    • Transmission-blocking anti-tick vaccines

Important Dates

February 1:      Open Call for Abstracts

March 5:           Deadline for Abstract Submission

April 1:              Abstract Determinations Emailed to Presenting Authors

May 1:               Open Registration begins

June 4:               Registration Deadline for non-US citizens (security applications due)

August 10:        Registration Deadline for US citizens (security applications due)